Guideline Central Blog

Guidelines Library

Clinical Experts

The significance behind their role when developing clinical practice guidelines! In our previous article, we’ve talked about how clinical practice guidelines (CPGs) are developed by a panel of experts based on current evidence. But who are these clinical experts and why do they play an important role when a guideline is published or updated? Developing […]

Clinical Guidelines vs. Primary Studies

Why are healthcare providers encouraged to follow clinical guidelines rather than individual primary studies? Still not familiar with what clinical practice guidelines are? How they are disseminated? We’ve highlighted what they are and how they are disseminated in our previous article. As you may already know, clinical practice guidelines (CPGs) summarize the best available evidence in […]

NEW CLINICAL GUIDELINES & FDA APPROVALS – MAY 2022 ALERT

MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS? No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.  CLINICAL GUIDELINES ACMG Clinical Evaluation and Etiologic Diagnosis of Hearing Loss ASCO Exercise, Diet, and Weight Management During Cancer Treatment Systemic Therapy for Advanced Human Epidermal Growth […]

Clinical Guidelines Explained

Clinical Guidelines: What are they & how are they disseminated? Clinical practices that are based on graded research findings are more reliable than that based on an “expert opinion”. So, more focus should be directed toward identifying and understanding these graded research findings called guidelines. Guidelines, also called clinical practice guidelines (CPG), are documents containing […]

NEW CLINICAL GUIDELINES & FDA APPROVALS – APRIL 2022 ALERT

MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS? No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.  CLINICAL GUIDELINES ACC/AHA/HFSA Management of Heart Failure (2022 Update) ASCO Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer Biomarkers for […]

Where Are The Guidelines Now? Three Months After the Closure of AHRQ’s NGC

It’s been roughly three months since the closure of Agency for Healthcare Research and Quality’s (AHRQ) National Guideline Clearinghouse (NGC) on July 16, 2018. The defunding and closure of NGC left a significant gap in the healthcare community that yet remains to be filled. AHRQ stated that approximately 2.4 million healthcare professionals visited the NGC […]